SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-22-000377
Filing Date
2022-02-14
Accepted
2022-02-14 16:34:00
Documents
2
Group Members
VIRPAX PHARMACEUTICALS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G virpax_13gdec312021.htm SC 13G 54300
2 JOINT FILING AGREEMENT virpax_13gdec312021ex1.htm EX-1 4234
  Complete submission text file 0000905718-22-000377.txt   59942
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Subject) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92861 | Film No.: 22633130
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Mack Anthony P. (Filed by) CIK: 0001818483 (see all company filings)

Type: SC 13G